Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase

Clinical trial NCT01699217 · COMPLETED

Trial details

NCT number: NCT01699217
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Phase Philadelphia Positive BCR-ABL Positive Chronic Myeloid Leukaemia

Start date: 2013-06-21
Primary completion: 2017-12-16
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.